Prenatal BPA Exposure Linked to Wheeze
Asthma rates of children in the US have risen steadily over the past 30 years, but specific causes for the increase have remained unclear.
FDA Adds Important Safety Information to Xolair Label
An FDA review of safety studies suggests a slightly increased risk of problems involving the heart and blood vessels supplying the brain among patients being treated with the asthma drug Xolair (omalizumab) than in those who were not treated with Xolair.
FDA Approves New Use of Glucose Monitoring System for Hospitals
Today the U.S. Food and Drug Administration cleared a new indication for the Nova StatStrip Glucose Hospital Meter System, extending its use to critically ill patients who have been hospitalized.
Schools May Be Unprepared for Chronic Health Emergencies
Some school districts may be unprepared for emergencies related to chronic conditions like asthma and allergies, a new study found. The authors of the study called for more health management plans in schools.
Combo Therapy May Be Best for COPD
A therapy including two types of inhaled medication could be the best treatment for COPD, a smoking-related condition that affects millions in the US each year.
Dad’s Smoking May Affect Future Children
Secondhand smoke can be harmful to children. But it may also harm children before they're even born.
Weight May Trigger Asthma in Kids
There’s an established and complex link between asthma and obesity. But which one comes first in children?
Pulmonary Disease May Increase Lung Cancer Risk
Medical conditions that affect breathing can take an immediate toll on health and may set the stage for other serious problems later in life.
FDA Approves New Device to Preserve Donated Lungs
The US Food and Drug Administration (FDA) has approved a new device to preserve donated lungs. According to the agency, the device might lead to more lung transplants.
Rx for Rare Genetic Disorder Now Approved for Patients of All Ages
The U.S. Food and Drug Administration today announced the approval of Lumizyme (alglucosidase alfa) for treatment of patients with infantile-onset Pompe disease, including patients who are less than 8 years of age.